Therewith, alike trends were recorded in the case of the IL-10 and the TGF-β anti-inflammatory cytokines, whose relative expression of their encoding genes has increased following treatment with calystegines, hinting at the potent regulatory effect of calystegines towards the impaired immunomodulatory properties of HuASCs cells affected by hyperglycaemia. The gene discussed is IL10; the disease is Hyperglycemia.